Related Experiment Video
Updated: Jun 13, 2026

Intravital Imaging of Neutrophil Priming Using IL-1β Promoter-driven DsRed Reporter Mice
Published on: June 22, 2016
[IL-27 regulates the expression of Mac-1, fMLP-R and IL-1beta in human neutrophils through p38 MAPK and PI3K signal
Jian-Ping Li1, Shao-Guang Yang, Chun-Lan Dong
1State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
Abstract:
The present study was aimed to investigate the pathways, by which IL-27 regulates the expression of adherent molecule Mac-1, chemotactic factor receptor fMLP-R and pro-inflammatory cytokine IL-1beta in human neutrophils. Highly purified human neutrophils were isolated from peripheral blood using Ficoll-Hypaque gradients centrifugation and erythrocyte lysis. The mRNA expression of IL-27 receptor components (WSX-1/TCCR and gp130) in human neutrophils was detected by reverse transcription polymerase chain reaction (RT-PCR). After incubation with IL-27 and specific inhibitors (p38 MAPK inhibitor SB203580, PI3K inhibitor LY294002 and ERK inhibitor U0126), the mRNA levels of fMLP-R and IL-1beta were determined by real time RT-PCR, and the adherent molecule Mac-1 expression in human neutrophils was determined by flow cytometry. The IL-1beta level in culture supernatant of human neutrophils was assayed by radioimmunoassay. The results showed that IL-27 receptor components (WSX-1/TCCR and gp130) were constitutively expressed in human neutrophils. IL-27 down-regulated Mac-1 expression in human neutrophils (p<0.05). After incubation with specific inhibitors, SB203580, not LY294002 and U0126, inhibited the down-regulation of Mac-1 expression by IL-27. However, IL-27 up-regulated the mRNA expression of fMLP-R and IL-1beta, and increased the release of IL-1beta (p<0.05). Interestingly, LY294002, not SB203580 and U0126, inhibited the up-regulation of fMLP-R and IL-1beta by IL-27. It is concluded that the IL-27 may regulate the expression of Mac-1, fMLP-R and IL-1beta in human neutrophils through p38 MAPK and PI3K signal pathways.
Insights
Interleukin-27 (IL-27) modulates human neutrophil responses by regulating Mac-1, fMLP-R, and IL-1beta. These effects are mediated through distinct p38 MAPK and PI3K signaling pathways.
Area of Science:
- Immunology
- Cell Biology
Background:
- Interleukin-27 (IL-27) is a cytokine with diverse immune regulatory functions.
- Human neutrophils play a critical role in innate immunity and inflammation.
- Understanding IL-27's impact on neutrophil function is crucial for inflammatory disease research.
Purpose of the Study:
- To elucidate the molecular pathways through which IL-27 regulates Mac-1, fMLP-R, and IL-1beta in human neutrophils.
- To identify the specific signaling cascades involved in IL-27-mediated neutrophil modulation.
Main Methods:
- Human neutrophils were isolated and stimulated with IL-27.
- Expression of IL-27 receptor components (WSX-1/TCCR and gp130) was confirmed via RT-PCR.
- Effects of IL-27 and pathway inhibitors (SB203580, LY294002, U0126) on Mac-1, fMLP-R, and IL-1beta were assessed using RT-PCR, real-time RT-PCR, flow cytometry, and radioimmunoassay.
Main Results:
- IL-27 receptor components are constitutively expressed in human neutrophils.
- IL-27 down-regulated Mac-1 expression, an effect dependent on p38 MAPK.
- IL-27 up-regulated fMLP-R and IL-1beta expression and release, mediated by PI3K signaling.
Conclusions:
- IL-27 differentially regulates Mac-1, fMLP-R, and IL-1beta in human neutrophils.
- The p38 MAPK pathway mediates IL-27's effect on Mac-1 expression.
- The PI3K pathway mediates IL-27's effect on fMLP-R and IL-1beta expression and release.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway

